Documentos relacionados

1. The impact of the American Heart Association guidelines on patients treated for incomplete Kawasaki disease.
2. [Predictive value of peripheral blood lymphocyte subsets for children with intravenous immunoglobulin-resistant Kawasaki disease].
3. Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.
4. Effectiveness of two same-manufacturer intravenous immunoglobulin for Kawasaki disease.
5. NLRC4 methylation and its response to intravenous immunoglobulin therapy in Kawasaki disease: a case control study.
6. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
7. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
8. Pediatric expert consensus on the application of glucocorticoids in Kawasaki disease.
9. Infliximab as a second-line therapy for children with refractory Kawasaki disease: A systematic review and meta-analysis of randomized controlled trials.
10. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.